Spinal Modulation Starts U.S. Pain Trial For Axium Neurostimulator System
This article was originally published in The Gray Sheet
Executive Summary
The noninferiority trial will compare Axium, which targets the dorsal root ganglion rather than the spinal cord directly, to approved spinal cord stimulation devices in about 150 patients with chronic lower-limb pain.